Assessing the Impact of Hepatitis B Elimination Program on Maternal-Infant Health in West Java, Indonesia: A Cross-Sectional Study

24 August 2023 : Clinical Research

Anita Deborah Anwar

^1ABCDEFG, Annisa Dewi Nugrahani

^1ABCDEF*, Dhanny Primantara Johari Santoso

^1ABCDE, Muhammad Alamsyah Aziz

^2ADEF, Lia Ulfah^3BCD, Asep Surachman^4B

DOI: 10.12659/MSM.941639

Med Sci Monit 2023; 29:e941639

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 2 Characteristics of the infants.

Variables	Total (n=62)	Percentage (%)

Yes	40	64.51
No	22	35.49

Yes	45	72.58
No	17	27.42

Yes	59	95.16
No	3	4.84

Reactive	2	3.22
Non-Reactive	60	96.78
HBIG – hepatitis B immune globulin; HBV vaccine – hepatitis B vaccine.

Back to the Article